InstitutionMD Anderson
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Longtain RB, Graham DP, Harding MJ, De La Garza Ii R, Nielsen DA. Methylation of the serotonin transporter gene moderates the depressive subjective effect of cocaine. Behav Brain Res. 2022 02 10; 418:113675. PMID: 34798166; PMCID: PMC8671356.
      Citations:    Fields:    Translation:HumansCells
    2. Mahoney JJ, Thompson-Lake DG, Cooper K, Verrico CD, Newton TF, De La Garza R. A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders. J Psychopharmacol. 2015 Jan; 29(1):50-6. PMID: 25424624.
      Citations: 28     Fields:    Translation:Humans
    3. Kalechstein AD, Mahoney JJ, Verrico CD, De La Garza R. Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users. Neuropharmacology. 2014 Oct; 85:493-8. PMID: 24930359.
      Citations: 3     Fields:    Translation:Humans
    4. Mahoney JJ, De La Garza R, Jackson BJ, Verrico CD, Ho A, Iqbal T, Newton TF. The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Res. 2014 Oct 30; 219(2):367-71. PMID: 24951161; PMCID: PMC4119803.
      Citations: 17     Fields:    Translation:Humans
    5. Yoon JH, Shah RS, Arnoudse NM, De La Garza R. Remote physiological monitoring of acute cocaine exposure. J Med Eng Technol. 2014 Jul; 38(5):244-50. PMID: 24841843.
      Citations: 4     Fields:    Translation:Humans
    6. Spellicy CJ, Harding MJ, Hamon SC, Mahoney JJ, Reyes JA, Kosten TR, Newton TF, De La Garza R, Nielsen DA. A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study. Genes Brain Behav. 2014 Jul; 13(6):559-64. PMID: 24528631; PMCID: PMC4079840.
      Citations: 8     Fields:    Translation:Humans
    7. Verrico CD, Mahoney JJ, Thompson-Lake DG, Bennett RS, Newton TF, De La Garza R. Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol. 2014 Feb; 17(2):223-33. PMID: 24393456; PMCID: PMC4423531.
      Citations: 9     Fields:    Translation:Humans
    8. Baeza-Loya S, Viswanath H, Carter A, Molfese DL, Velasquez KM, Baldwin PR, Thompson-Lake DG, Sharp C, Fowler JC, De La Garza R, Salas R. Perceptions about e-cigarette safety may lead to e-smoking during pregnancy. Bull Menninger Clin. 2014; 78(3):243-52. PMID: 25247743; PMCID: PMC4458373.
      Citations: 50     Fields:    Translation:Humans
    9. De La Garza R, Galloway GP, Newton TF, Mendelson J, Haile CN, Dib E, Hawkins RY, Chen CY, Mahoney JJ, Mojsiak J, Lao G, Anderson A, Kahn R. Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 03; 50:44-52. PMID: 24316175; PMCID: PMC4562471.
      Citations: 1     Fields:    Translation:Humans
    10. Mahoney JJ, Kalechstein AD, Verrico CD, Arnoudse NM, Shapiro BA, De La Garza R. Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 03; 50:137-42. PMID: 24239594; PMCID: PMC4432863.
      Citations: 4     Fields:    Translation:Humans
    11. Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A, Iqbal S, Mahoney JJ, De La Garza R, Charney DS, Newton TF, Mathew SJ. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol. 2014 Feb; 17(2):331-6. PMID: 24103211; PMCID: PMC3992942.
      Citations: 82     Fields:    Translation:Humans
    12. Verrico CD, Haile CN, Newton TF, Kosten TR, De La Garza R, De La Garza R. Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opin Investig Drugs. 2013 Dec; 22(12):1549-68. PMID: 24033127; PMCID: PMC4422382.
      Citations: 19     Fields:    Translation:HumansAnimals
    13. Haile CN, De La Garza R, Mahoney JJ, Newton TF. Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase. Drug Alcohol Depend. 2013 Dec 01; 133(2):759-62. PMID: 23968815; PMCID: PMC4432865.
      Citations: 4     Fields:    Translation:Humans
    14. Ross EL, Yoon JH, Mahoney JJ, Omar Y, Newton TF, De La Garza R. The impact of self-reported life stress on current impulsivity in cocaine dependent adults. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 01; 46:113-9. PMID: 23796525; PMCID: PMC3955062.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    15. Chang LC, Mahoney JJ, Raty SR, Ortiz J, Apodaca S, De La Garza R. Neurocognitive effects following an overnight call shift on faculty anesthesiologists. Acta Anaesthesiol Scand. 2013 Sep; 57(8):1051-7. PMID: 23593975.
      Citations: 3     Fields:    Translation:Humans
    16. Brewer AJ, Mahoney JJ, Nerumalla CS, Newton TF, De La Garza R. The influence of smoking cigarettes on the high and desire for cocaine among active cocaine users. Pharmacol Biochem Behav. 2013 May; 106:132-6. PMID: 23541494; PMCID: PMC3707485.
      Citations: 14     Fields:    Translation:HumansAnimals
    17. Haile CN, De La Garza R, Mahoney JJ, Nielsen DA, Kosten TR, Newton TF. The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial. PLoS One. 2012; 7(11):e47702. PMID: 23144826; PMCID: PMC3493584.
      Citations: 14     Fields:    Translation:Humans
    18. Kalechstein AD, Yoon JH, Mahoney JJ, Newton TF, Chang L, De La Garza R. d-Cycloserine administration does not affect neurocognition in concurrent cocaine- and nicotine-dependent volunteers. Pharmacol Biochem Behav. 2012 Dec; 103(2):403-7. PMID: 22960612.
      Citations:    Fields:    Translation:Humans
    19. Kalechstein AD, Mahoney JJ, Yoon JH, Bennett R, De la Garza R. Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users. Neuropharmacology. 2013 Jan; 64:472-8. PMID: 22796108.
      Citations: 24     Fields:    Translation:Humans
    20. Mahoney JJ, Newton TF, Omar Y, Ross EL, De La Garza R. The relationship between lifetime stress and addiction severity in cocaine-dependent participants. Eur Neuropsychopharmacol. 2013 May; 23(5):351-7. PMID: 22748418.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    21. Yoon JH, Newton TF, Haile CN, Bordnick PS, Fintzy RE, Culbertson C, Mahoney JJ, Hawkins RY, LaBounty KR, Ross EL, Aziziyeh AI, La Garza R. Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers. Addict Behav. 2013 Feb; 38(2):1518-1526. PMID: 22560371; PMCID: PMC3415581.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    22. Newton TF, De La Garza R, Brown G, Kosten TR, Mahoney JJ, Haile CN. Noradrenergic a1 receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial. PLoS One. 2012; 7(2):e30854. PMID: 22319592; PMCID: PMC3272014.
      Citations: 27     Fields:    Translation:Humans
    23. Haile CN, Mahoney JJ, Newton TF, De La Garza R. Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther. 2012 May; 134(2):260-77. PMID: 22327234; PMCID: PMC3341931.
      Citations: 24     Fields:    Translation:HumansAnimals
    24. Mahoney JJ, Jackson BJ, Kalechstein AD, De La Garza R, Chang LC, Newton TF. Acute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteers. Int J Neuropsychopharmacol. 2012 Oct; 15(9):1241-9. PMID: 22214752; PMCID: PMC3411896.
      Citations: 7     Fields:    Translation:Humans
    25. De La Garza R, Newton TF, Haile CN, Yoon JH, Nerumalla CS, Mahoney JJ, Aziziyeh A. Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27; 37(1):141-6. PMID: 22230648; PMCID: PMC3877939.
      Citations: 16     Fields:    Translation:Humans
    26. De la Garza R, Yoon JH. Evaluation of the effects of rivastigmine on cigarette smoking by methamphetamine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 01; 35(8):1827-30. PMID: 21803113; PMCID: PMC3877941.
      Citations: 10     Fields:    Translation:Humans
    27. Roache JD, Kahn R, Newton TF, Wallace CL, Murff WL, De La Garza R, Rivera O, Anderson A, Mojsiak J, Elkashef A. A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram. Drug Alcohol Depend. 2011 Dec 01; 119(1-2):37-45. PMID: 21696894; PMCID: PMC3205249.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    28. Kalechstein AD, Yoon JH, Croft DE, Jaeggi S, Mahoney JJ, De La Garza R. Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals. Pharmacol Biochem Behav. 2011 Sep; 99(3):423-7. PMID: 21624391.
      Citations: 4     Fields:    Translation:Humans
    29. Tziortzis D, Mahoney JJ, Kalechstein AD, Newton TF, De La Garza R. The relationship between impulsivity and craving in cocaine- and methamphetamine-dependent volunteers. Pharmacol Biochem Behav. 2011 Apr; 98(2):196-202. PMID: 21215769.
      Citations: 20     Fields:    Translation:Humans
    30. Mahoney JJ, Jackson BJ, Kalechstein AD, De La Garza R, Newton TF. Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30; 35(2):459-65. PMID: 21122811; PMCID: PMC3341926.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    31. Mahoney JJ, Hawkins RY, De La Garza R, Kalechstein AD, Newton TF. Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants. Gend Med. 2010 Oct; 7(5):414-21. PMID: 21056868; PMCID: PMC3342664.
      Citations: 23     Fields:    Translation:Humans
    32. Culbertson C, Nicolas S, Zaharovits I, London ED, De La Garza R, Brody AL, Newton TF. Methamphetamine craving induced in an online virtual reality environment. Pharmacol Biochem Behav. 2010 Oct; 96(4):454-60. PMID: 20643158; PMCID: PMC2951480.
      Citations: 34     Fields:    Translation:Humans
    33. Kalechstein AD, De La Garza R, Newton TF. Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment. Am J Addict. 2010 Jul-Aug; 19(4):340-4. PMID: 20653641; PMCID: PMC3341927.
      Citations: 25     Fields:    Translation:Humans
    34. Newton TF, De La Garza R, Grasing K. The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humans. Psychiatry Res. 2010 Aug 30; 179(1):96-100. PMID: 20493549; PMCID: PMC2919653.
      Citations: 6     Fields:    Translation:Humans
    35. De La Garza R, Ashbrook LH, Evans SE, Jacobsen CA, Kalechstein AD, Newton TF. Influence of verbal recall of a recent stress experience on anxiety and desire for cocaine in non-treatment seeking, cocaine-addicted volunteers. Am J Addict. 2009 Nov-Dec; 18(6):481-7. PMID: 19874169; PMCID: PMC3341928.
      Citations: 4     Fields:    Translation:Humans
    36. De La Garza R, Zorick T, London ED, Newton TF. Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug Alcohol Depend. 2010 Jan 15; 106(2-3):173-80. PMID: 19781865; PMCID: PMC2815156.
      Citations: 36     Fields:    Translation:Humans
    37. De La Garza R, Zorick T, Heinzerling KG, Nusinowitz S, London ED, Shoptaw S, Moody DE, Newton TF. The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. Pharmacol Biochem Behav. 2009 Nov; 94(1):186-93. PMID: 19698734; PMCID: PMC2775447.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    38. Newton TF, De La Garza R, Kalechstein AD, Tziortzis D, Jacobsen CA. Theories of addiction: methamphetamine users' explanations for continuing drug use and relapse. Am J Addict. 2009 Jul-Aug; 18(4):294-300. PMID: 19444733; PMCID: PMC3341929.
      Citations: 29     Fields:    Translation:Humans
    39. Culbertson C, De La Garza R, Costello M, Newton TF. Unrestricted access to methamphetamine or cocaine in the past is associated with increased current use. Int J Neuropsychopharmacol. 2009 Jun; 12(5):677-85. PMID: 19220922; PMCID: PMC2735335.
      Citations: 1     Fields:    Translation:Humans
    40. Kalechstein AD, De la Garza R, Newton TF, Green MF, Cook IA, Leuchter AF. Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci. 2009; 21(3):254-8. PMID: 19776303; PMCID: PMC3350803.
      Citations: 8     Fields:    Translation:Humans
    41. Newton TF, Reid MS, De La Garza R, Mahoney JJ, Abad A, Condos R, Palamar J, Halkitis PN, Mojisak J, Anderson A, Li SH, Elkashef A. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol. 2008 Dec; 11(8):1037-45. PMID: 18664303; PMCID: PMC2782728.
      Citations: 19     Fields:    Translation:Humans
    42. Shoptaw S, Heinzerling KG, Rotheram-Fuller E, Steward T, Wang J, Swanson AN, De La Garza R, Newton T, Ling W. Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2008 Aug 01; 96(3):222-32. PMID: 18468815; PMCID: PMC3652530.
      Citations: 64     Fields:    Translation:HumansPHPublic Health
    43. Singh HH, Rapaka RS, Shurtleff D, De La Garza R. NIDA drug supply and analytical services program: providing research resources and tools to the scientific community. Drug Alcohol Depend. 2008 May 01; 95(1-2):182-6. PMID: 18484110.
      Citations:    Fields:    Translation:Humans
    44. Mahoney JJ, Kalechstein AD, De La Garza R, Newton TF. Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants. Am J Addict. 2008 Mar-Apr; 17(2):83-98. PMID: 18393050; PMCID: PMC4119877.
      Citations: 33     Fields:    Translation:Humans
    45. Fleury G, De La Garza R, Mahoney JJ, Evans SE, Newton TF. Predictors of cardiovascular response to methamphetamine administration in methamphetamine-dependent individuals. Am J Addict. 2008 Mar-Apr; 17(2):103-10. PMID: 18393052.
      Citations: 4     Fields:    Translation:Humans
    46. De La Garza R, Shoptaw S, Newton TF. Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers. Int J Neuropsychopharmacol. 2008 Sep; 11(6):729-41. PMID: 18248689; PMCID: PMC2581751.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    47. De La Garza R, Mahoney JJ, Culbertson C, Shoptaw S, Newton TF. The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. Pharmacol Biochem Behav. 2008 Apr; 89(2):200-8. PMID: 18207225; PMCID: PMC4170947.
      Citations: 25     Fields:    Translation:Humans
    48. Fantegrossi WE, Ciullo JR, Wakabayashi KT, De La Garza R, Traynor JR, Woods JH. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. Neuroscience. 2008 Jan 24; 151(2):533-43. PMID: 18082974; PMCID: PMC2276981.
      Citations: 53     Fields:    Translation:AnimalsCells
    49. Rotheram-Fuller E, De La Garza R, Mahoney JJ, Shoptaw S, Newton TF. Subjective and cardiovascular effects of cocaine during treatment with amantadine and baclofen in combination. Psychiatry Res. 2007 Aug 30; 152(2-3):205-10. PMID: 17449110.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    50. Mahoney JJ, Kalechstein AD, De La Garza R, Newton TF. A qualitative and quantitative review of cocaine-induced craving: the phenomenon of priming. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13; 31(3):593-9. PMID: 17270333; PMCID: PMC1907363.
      Citations: 13     Fields:    Translation:Humans
    51. Kalechstein AD, De La Garza R, Mahoney JJ, Fantegrossi WE, Newton TF. MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl). 2007 Jan; 189(4):531-7. PMID: 17082969.
      Citations: 47     Fields:    Translation:Humans
    52. Asnis GM, De La Garza R. Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. J Clin Gastroenterol. 2006 Apr; 40(4):322-35. PMID: 16633105.
      Citations: 55     Fields:    Translation:Humans
    53. De La Garza R, Fabrizio KR, Gupta A. Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns. Psychopharmacology (Berl). 2007 Jan; 189(4):425-34. PMID: 16470404.
      Citations: 24     Fields:    Translation:HumansAnimals
    54. Newton TF, De La Garza R, Fong T, Chiang N, Holmes TH, Bloch DA, Anderson A, Elkashef A. A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline. Pharmacol Biochem Behav. 2005 Dec; 82(4):704-11. PMID: 16413604.
      Citations: 10     Fields:    Translation:Humans
    55. Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology. 2006 Jul; 31(7):1537-44. PMID: 16319910.
      Citations: 66     Fields:    Translation:HumansCTClinical Trials
    56. Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology (Berl). 2005 Nov; 182(3):426-35. PMID: 16163531.
      Citations: 31     Fields:    Translation:HumansCTClinical Trials
    57. De La Garza R. Wistar Kyoto rats exhibit reduced sucrose pellet reinforcement behavior and intravenous nicotine self-administration. Pharmacol Biochem Behav. 2005 Oct; 82(2):330-7. PMID: 16226802.
      Citations: 8     Fields:    Translation:Animals
    58. Fantegrossi WE, Kiessel CL, De la Garza R, Woods JH. Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse. Psychopharmacology (Berl). 2005 Sep; 181(3):529-36. PMID: 15983787.
      Citations: 12     Fields:    Translation:Animals
    59. Fong TW, De La Garza R, Newton TF. A case report of topiramate in the treatment of nonparaphilic sexual addiction. J Clin Psychopharmacol. 2005 Oct; 25(5):512-4. PMID: 16160641.
      Citations: 3     Fields:    Translation:Humans
    60. Newton TF, Kalechstein AD, De La Garza R, Cutting DJ, Ling W. Apathy predicts hedonic but not craving response to cocaine. Pharmacol Biochem Behav. 2005 Sep; 82(1):236-40. PMID: 16181666.
      Citations: 4     Fields:    Translation:Humans
    61. Newton TF, De La Garza R, Kalechstein AD, Nestor L. Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects. Pharmacol Biochem Behav. 2005 Sep; 82(1):90-7. PMID: 16112720.
      Citations: 39     Fields:    Translation:Humans
    62. Asnis GM, De La Garza R. Interferon-induced depression: strategies in treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun; 29(5):808-18. PMID: 15907352.
      Citations: 15     Fields:    Translation:Humans
    63. De La Garza R, Asnis GM, Pedrosa E, Stearns C, Migdal AL, Reinus JF, Paladugu R, Vemulapalli S. Recombinant human interferon-alpha does not alter reward behavior, or neuroimmune and neuroendocrine activation in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun; 29(5):781-92. PMID: 15927336.
      Citations: 14     Fields:    Translation:HumansAnimals
    64. De La Garza R. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci Biobehav Rev. 2005; 29(4-5):761-70. PMID: 15878621.
      Citations: 49     Fields:    Translation:HumansAnimals
    65. Asnis GM, De La Garza R, Rego SA, Henderson MA, Reinus JF. Interferon for hepatitis C patients with psychiatric disorders. Am J Psychiatry. 2004 Dec; 161(12):2332; author reply 2332-4. PMID: 15569920.
      Citations: 1     Fields:    Translation:Humans
    66. Rifai MA, Bozorg B, Rosenstein DL. Interferon for hepatitis C patients with psychiatric disorders. Am J Psychiatry. 2004 Dec; 161(12):2331-2; author reply 2332-4. PMID: 15569919.
      Citations: 4     Fields:    Translation:HumansCells
    67. De La Garza R, Asnis GM, Fabrizio KR, Pedrosa E. Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats. Psychopharmacology (Berl). 2005 May; 179(2):356-65. PMID: 15565429.
      Citations: 13     Fields:    Translation:Animals
    68. De La Garza R, Newton TF, Kalechstein AD. Risperidone diminishes cocaine-induced craving. Psychopharmacology (Berl). 2005 Mar; 178(2-3):347-50. PMID: 15452684.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    69. De La Garza R, Mahoney JJ. A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression. Brain Res. 2004 Sep 24; 1021(2):209-18. PMID: 15342269.
      Citations: 44     Fields:    Translation:Animals
    70. Asnis GM, De La Garza R, Miller AH, Raison CL. Ribavirin may be an important factor in IFN-induced neuropsychiatric effects. J Clin Psychiatry. 2004 Apr; 65(4):581; author reply 581-2. PMID: 15119925.
      Citations: 4     Fields:    Translation:Humans
    71. De La Garza R, Fabrizio KR, Radoi GE, Vlad T, Asnis GM. The non-steroidal anti-inflammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations to reward behavior and corticosterone release. Behav Brain Res. 2004 Feb 04; 149(1):77-85. PMID: 14739012.
      Citations: 10     Fields:    Translation:Animals
    72. Madras BK, Fahey MA, Miller GM, De La Garza R, Goulet M, Spealman RD, Meltzer PC, George SR, O'Dowd BF, Bonab AA, Livni E, Fischman AJ. Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors. Eur J Pharmacol. 2003 Oct 31; 479(1-3):41-51. PMID: 14612136.
      Citations: 5     Fields:    Translation:Animals
    73. De La Garza R, Asnis GM. The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus. Brain Res. 2003 Jul 04; 977(1):70-9. PMID: 12788515.
      Citations: 14     Fields:    Translation:Animals
    74. Overstreet DH, Commissaris RC, De La Garza R, File SE, Knapp DJ, Seiden LS. Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. Stress. 2003 Jun; 6(2):101-10. PMID: 12775329.
      Citations: 28     Fields:    Translation:Animals
    75. Asnis GM, De La Garza R, Kohn SR, Reinus JF, Henderson M, Shah J. IFN-induced depression: a role for NSAIDs. Psychopharmacol Bull. 2003; 37(3):29-50. PMID: 14608239.
      Citations: 7     Fields:    Translation:Humans
    76. De La Garza R, Jentsch JD, Verrico CD, Roth RH. Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine. Brain Res. 2002 Dec 20; 958(1):20-7. PMID: 12468026.
      Citations: 6     Fields:    Translation:Animals
    77. Jentsch JD, Olausson P, De La Garza R, Taylor JR. Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys. Neuropsychopharmacology. 2002 Feb; 26(2):183-90. PMID: 11790514.
      Citations: 148     Fields:    Translation:Animals
    78. Miller GM, Yatin SM, De La Garza R, Goulet M, Madras BK. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. Brain Res Mol Brain Res. 2001 Feb 19; 87(1):124-43. PMID: 11223167.
      Citations: 19     Fields:    Translation:AnimalsCells
    79. Miller GM, De La Garza R, Novak MA, Madras BK. Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders. Mol Psychiatry. 2001 Jan; 6(1):50-8. PMID: 11244485.
      Citations: 14     Fields:    Translation:AnimalsCells
    80. De La Garza R, Madras BK. [(3)H]PNU-101958, a D(4) dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain. Synapse. 2000 Sep 01; 37(3):232-44. PMID: 10881045.
      Citations: 16     Fields:    Translation:Animals
    81. De La Garza R, Cunningham KA. The effects of the 5-hydroxytryptamine(1A) agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity. J Pharmacol Exp Ther. 2000 Feb; 292(2):610-7. PMID: 10640298.
      Citations: 10     Fields:    Translation:Animals
    82. De La Garza R, Meltzer PC, Madras BK. Non-amine dopamine transporter probe [(3)H]tropoxene distributes to dopamine-rich regions of monkey brain. Synapse. 1999 Oct; 34(1):20-7. PMID: 10459168.
      Citations: 5     Fields:    Translation:Animals
    83. De La Garza R, Callahan PM, Cunningham KA. The discriminative stimulus properties of cocaine: effects of microinfusion of cocaine, a 5-HT1A agonist or antagonist, into the ventral tegmental area. Psychopharmacology (Berl). 1998 May; 137(1):1-6. PMID: 9631950.
      Citations: 2     Fields:    Translation:Animals
    84. Callahan PM, De La Garza R, Cunningham KA. Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol Biochem Behav. 1997 Jul; 57(3):601-7. PMID: 9218282.
      Citations: 21     Fields:    Translation:Animals
    85. De La Garza R, Callahan PM, Cunningham KA. Detailed investigations of 5-HT3 compounds in a drug discrimination model. Pharmacol Biochem Behav. 1996 Jul; 54(3):533-40. PMID: 8743626.
      Citations: 3     Fields:    Translation:Animals
    86. Callahan PM, De La Garza R, Cunningham KA. Discriminative stimulus properties of cocaine: modulation by dopamine D1 receptors in the nucleus accumbens. Psychopharmacology (Berl). 1994 Jun; 115(1-2):110-4. PMID: 7862881.
      Citations: 7     Fields:    Translation:Animals
    87. Safety and preliminary efficacy of the acetylcholinesterase inhibitor huperzine a as a treatment for cocaine use disorder. International Journal of Neuropsychopharmacology. 19:1-9.
    88. Treadmill exercise improves fitness and reduces craving and use of cocaine in individuals with concurrent cocaine and tobacco-use disorder. Psychiatry Research. 245:133-140.
    89. Programmable bio-nano-chip system for saliva diagnostics.
    90. The α-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals. Pharmacogenetics and Genomics. 26:428-435.
    91. Anterior cingulum white matter is altered in tobacco smokers. American Journal on Addictions. 25:210-214.
    92. Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids. Drug and Alcohol Dependence. 153:306-313.
    93. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans. Psychiatry Research. 230:44-49.
    94. The relationship between premorbid IQ and neurocognitive functioning in individuals with cocaine use disorders. Neuropsychology.
    95. Alterations in interhemispheric functional and anatomical connectivity are associated with tobacco smoking in humans. Frontiers in Human Neuroscience. 9.
    96. Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. Pharmacogenetics and Genomics. 25:296-304.
    97. Erratum. Expert Opinion on Investigational Drugs. 23:885.
    98. A contemporary view of MDMA. Psychopharmacology. 189:403-405.
    99. Withdrawal symptoms and nicotine dependence severity predict virtual reality craving in cigarette-deprived smokers. Nicotine and Tobacco Research. 17:796-802.
    100. In search of animal models of cytokine-induced depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30:1366.
    DE LA GARZA II's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (371)
    Co-Authors (10)
    Similar People (60)
    Same Department Expand Description